Ex-Dividend Date Nearing for These 10 Stocks – Week of June 16, 2025
Dividend Stocks Near 52-Week Lows: This week, several dividend stocks are trading close to their 52-week lows and are approaching their ex-dividend dates, making them potential buys for investors looking to benefit from upcoming payouts.
List of Stocks: The article lists ten specific stocks (WU, OXSQ, HRZN, PDCC, RYN, FG, DOC, JJSF, GMRE, VIRC) that investors can consider purchasing before their ex-dividend dates to qualify for dividends.
Trade with 70% Backtested Accuracy
Analyst Views on GMRE
About GMRE
About the author
Global Medical REIT Rebrands to Chiron Real Estate with New Ticker XRN
- Rebranding Initiative: Global Medical REIT (GMRE) announced its name change to Chiron Real Estate effective February 23, aiming to align better with its redefined strategic mission, which reflects a clear direction for future growth.
- Ticker Symbol Change: Following the rebranding, the company's ticker symbol on the NYSE will change to XRN, while preferred stock symbols will shift to XRN PrA and XRN PrB, enhancing market recognition of the new brand.
- Strategic Focus Shift: CEO Mark Decker stated that after six months of evaluation, the rebranding aims to embody the company's expertise and mission in the medical field, thereby increasing its competitive edge in the market.
- Market Reaction Expectations: With the implementation of the rebranding, Chiron Real Estate is expected to attract more investor attention, particularly against the backdrop of growing demand in the medical real estate sector, potentially enhancing the company's market valuation and investment appeal.
Insider Buying Update for Tuesday, December 9: GMRE, PODD
CEO Purchase at Global Medical REIT: Mark Okey Decker Jr., CEO of Global Medical REIT, bought 10,000 shares at $32.51 each, totaling $325,100, and is currently up 7.3% based on recent trading highs.
Previous Investments by CEO: Decker Jr. has previously invested $1.58 million in GMRE over the past year, purchasing shares at an average price of $7.87.
Director Purchase at Insulet: Timothy C. Stonesifer, a director at Insulet, purchased 962 shares for $299,884 at $311.73 each, marking his first purchase in the last year.
Current Trading Status: Insulet shares are currently trading lower than Stonesifer's purchase price, with a recent low of $297.63, which is 4.5% below his buying price.
Global Medical REIT Announces $0.75 Dividend Payment
Quarterly Dividend Announcement: Global Medical REIT (GMRE) has declared a quarterly dividend of $0.75 per share, with a forward yield of 9.19%.
Dividend Payment Details: The dividend is payable on January 9, for shareholders of record on December 19, with an ex-dividend date also set for December 19.
Preferred Stock Offering: GMRE has priced a new preferred stock offering at $50 million, with shares priced at $25.00 each.
Market Activity: AEW Capital has exited six REITs in Q3 and initiated a position in American Tower, indicating shifts in investment strategies within the REIT sector.
Global Medical REIT Inc. Sets Price for Public Offering of 8.00% Series B Preferred Stock
Public Offering Announcement: Global Medical REIT Inc. has priced an underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, aiming to raise approximately $50 million before expenses, with the offering expected to close on November 20, 2025.
Use of Proceeds: The net proceeds from the offering will be utilized for general corporate purposes, which may include funding new acquisitions and repaying existing debt.
Underwriters and Listing: The offering is managed by several financial institutions, and the Company plans to list the Series B Preferred Stock on the New York Stock Exchange under the symbol "GMRE PrB."
Forward-Looking Statements: The press release includes forward-looking statements regarding the offering's closing, use of proceeds, and listing, which are subject to risks and uncertainties that could lead to different outcomes than anticipated.
Global Medical Announces $50M Preferred Stock Offering at $25.00 per Share
Public Offering Announcement: Global Medical REIT (GMRE) has priced an underwritten public offering of 2 million shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, aiming to raise approximately $50 million before expenses.
Use of Proceeds: The net proceeds from the offering will be used for general corporate purposes, including funding new acquisitions and repaying existing debt.
Closing Date: The transaction is expected to close on November 20, 2025, with underwriters granted a 30-day option to purchase an additional 300,000 shares.
Stock Exchange Listing: GMRE plans to apply for the new Series B Preferred Stock to be listed on the New York Stock Exchange under the ticker symbol "GMRE PrB."
Global Medical REIT Inc. Unveils Plans for Public Offering of Series B Preferred Stock
Public Offering Announcement: Global Medical REIT Inc. has initiated an underwritten public offering of its Series B Cumulative Redeemable Preferred Stock, with plans to grant underwriters a 30-day option for additional shares to cover over-allotments.
Use of Proceeds: The net proceeds from the offering are intended for general corporate purposes, including funding new acquisitions and repaying existing debt.
Listing Plans: The Company aims to list the Series B Preferred Stock on the New York Stock Exchange under the ticker symbol "GMRE-PrB."
Forward-Looking Statements: The announcement includes forward-looking statements regarding the offering and its expected outcomes, which are subject to risks and uncertainties that could lead to different actual results.
Global Medical REIT Rebrands to Chiron Real Estate with New Ticker XRN
- Rebranding Initiative: Global Medical REIT (GMRE) announced its name change to Chiron Real Estate effective February 23, aiming to align better with its redefined strategic mission, which reflects a clear direction for future growth.
- Ticker Symbol Change: Following the rebranding, the company's ticker symbol on the NYSE will change to XRN, while preferred stock symbols will shift to XRN PrA and XRN PrB, enhancing market recognition of the new brand.
- Strategic Focus Shift: CEO Mark Decker stated that after six months of evaluation, the rebranding aims to embody the company's expertise and mission in the medical field, thereby increasing its competitive edge in the market.
- Market Reaction Expectations: With the implementation of the rebranding, Chiron Real Estate is expected to attract more investor attention, particularly against the backdrop of growing demand in the medical real estate sector, potentially enhancing the company's market valuation and investment appeal.
Insider Buying Update for Tuesday, December 9: GMRE, PODD
CEO Purchase at Global Medical REIT: Mark Okey Decker Jr., CEO of Global Medical REIT, bought 10,000 shares at $32.51 each, totaling $325,100, and is currently up 7.3% based on recent trading highs.
Previous Investments by CEO: Decker Jr. has previously invested $1.58 million in GMRE over the past year, purchasing shares at an average price of $7.87.
Director Purchase at Insulet: Timothy C. Stonesifer, a director at Insulet, purchased 962 shares for $299,884 at $311.73 each, marking his first purchase in the last year.
Current Trading Status: Insulet shares are currently trading lower than Stonesifer's purchase price, with a recent low of $297.63, which is 4.5% below his buying price.
Global Medical REIT Announces $0.75 Dividend Payment
Quarterly Dividend Announcement: Global Medical REIT (GMRE) has declared a quarterly dividend of $0.75 per share, with a forward yield of 9.19%.
Dividend Payment Details: The dividend is payable on January 9, for shareholders of record on December 19, with an ex-dividend date also set for December 19.
Preferred Stock Offering: GMRE has priced a new preferred stock offering at $50 million, with shares priced at $25.00 each.
Market Activity: AEW Capital has exited six REITs in Q3 and initiated a position in American Tower, indicating shifts in investment strategies within the REIT sector.
Global Medical REIT Inc. Sets Price for Public Offering of 8.00% Series B Preferred Stock
Public Offering Announcement: Global Medical REIT Inc. has priced an underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, aiming to raise approximately $50 million before expenses, with the offering expected to close on November 20, 2025.
Use of Proceeds: The net proceeds from the offering will be utilized for general corporate purposes, which may include funding new acquisitions and repaying existing debt.
Underwriters and Listing: The offering is managed by several financial institutions, and the Company plans to list the Series B Preferred Stock on the New York Stock Exchange under the symbol "GMRE PrB."
Forward-Looking Statements: The press release includes forward-looking statements regarding the offering's closing, use of proceeds, and listing, which are subject to risks and uncertainties that could lead to different outcomes than anticipated.
Global Medical Announces $50M Preferred Stock Offering at $25.00 per Share
Public Offering Announcement: Global Medical REIT (GMRE) has priced an underwritten public offering of 2 million shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, aiming to raise approximately $50 million before expenses.
Use of Proceeds: The net proceeds from the offering will be used for general corporate purposes, including funding new acquisitions and repaying existing debt.
Closing Date: The transaction is expected to close on November 20, 2025, with underwriters granted a 30-day option to purchase an additional 300,000 shares.
Stock Exchange Listing: GMRE plans to apply for the new Series B Preferred Stock to be listed on the New York Stock Exchange under the ticker symbol "GMRE PrB."
Global Medical REIT Inc. Unveils Plans for Public Offering of Series B Preferred Stock
Public Offering Announcement: Global Medical REIT Inc. has initiated an underwritten public offering of its Series B Cumulative Redeemable Preferred Stock, with plans to grant underwriters a 30-day option for additional shares to cover over-allotments.
Use of Proceeds: The net proceeds from the offering are intended for general corporate purposes, including funding new acquisitions and repaying existing debt.
Listing Plans: The Company aims to list the Series B Preferred Stock on the New York Stock Exchange under the ticker symbol "GMRE-PrB."
Forward-Looking Statements: The announcement includes forward-looking statements regarding the offering and its expected outcomes, which are subject to risks and uncertainties that could lead to different actual results.
